The AMR Narrative

Why is Hand Hygiene fundamental to combatting Antimicrobial Resistance (AMR)?

Infection Prevention and Control (IPC) is a practical, evidence-based approach to prevent avoidable infections in health care settings, including those caused by anti-microbial resistant germs. Antimicrobial Resistance (AMR) occurs when an infection no longer responds to the medicines that were designed to treat them (i.e. antimicrobials including antibiotics, antifungals, antiparasitics, and antivirals). No one should get sick while receiving or providing health care. However, no country can claim to be free of what are called Healthcare Associated Infections (HAIs) which unfortunately are one of the most common patient safety risks. Some of the well-known potentially harmful organisms or germs include (not limited to) Clostridium difficile (C. difficile), Carbapenem-resistant Enterobacteriaceae (CRE), Staphylococcus aureus, Methicillin-resistant Staphylococcus aureus (MRSA) and of concern, Extended-spectrum beta-lactamase (ESBL) gram negative organisms like Pseudomonas aeruginosa.

Strengthening IPC programmes and best practices and ensuring access to safe water, sanitation, and hygiene (WASH) in all healthcare settings can achieve a significant reduction in the rates of infection and as such reduce death or disability from these infections.

The inappropriate use of antimicrobial medicines accelerates the emergence and spread of AMR infections.
IPC provides a way to curb the spread of resistant infections in hospitals, reducing the need for them. In healthcare, IPC, including hand hygiene at the appropriate times, effective WASH and the responsible use of antimicrobial medicines (antimicrobial stewardship), all allow for an effective approach to addressing this global issue. Ultimately, this approach saves lives, curtails healthcare costs, and alleviates an unnecessary burden on healthcare systems.

Hand hygiene is still one of the most effective things we can all do to keep people safe from infections in healthcare. So, sharing knowledge about hand hygiene is important. There are many reasons why educating and changing behaviours of health and care workers and others, including patients, is challenging, along with the successful implementation of turning knowledge into practice. This includes pressures on time, lack of resources, human and otherwise – and in some countries including a lack of running water – etc. Health literacy can also be a challenge in many settings. Raising awareness about the importance of learning on hand hygiene at the right times to prevent a range of infectious diseases and AMR has been highlighted by many leading organizations including the World Health Organization (WHO).

Ultimately, hand hygiene stops the spread of harmful infections, some of which are resistant to antimicrobial medicines; it saves lives – yours, a loved ones or someone most vulnerable in society – so why would we not want to commit to this!

 

The WHO, like other organizations, has a range of tools to help people and patients engage in positive conversations in healthcare, if appropriate and possible. One tool highlights actions such as; asking if there is an initiative involving patients or a patient participation programme for hand hygiene? Observing if alcohol-based handrub dispensers, as well as sinks, soap and towels are available for health workers to readily use when caring for you, and if hand hygiene products are available, to start by thanking your doctor, nurse, or other health worker for using them. In addition, patients have the right to ask for more information around how to perform hand hygiene and politely remind health care workers to clean their hands before they touch them, particularly if they are working with a wound dressing, catheter, drainage tube or any other situation that creates an opportunity for a deadly germ to enter their body.  

 

In another tool launched in 2017, the WHO also highlighted to patients and others the key times for their own hand hygiene in healthcare to support control of AMR such as; a) before touching a/their own wound dressing or IV line site, b) after touching other patients, c) after using the toilet. It is equally important for patients to make sure that objects they bring into a healthcare setting are kept clean, for example a mobile phone, but more importantly after touching their own items and before touching their loved one without cleaning their hands!

 

In addition, each year the WHO focuses on empowering different target audiences to get involved in their World Hand Hygiene Day campaign including those receiving health care/members of the public.

 

Image credit: https://www.who.int/campaigns/world-hand-hygiene-day/world-hand-hygiene-day-2024

Beyond healthcare setting walls, consideration is equally important in our own communities. At the height of the COVID-19 pandemic, the British Psychological Society provided examples of empowering people to consider the timings for their own hand hygiene. It centred on the if/when concept, aiding individuals in planning and preparing to clean their hands at crucial moments to safeguard themselves. This approach could diminish the spread and the risk of acquiring AMR infections, which are also prevalent in the community, food, animals, and the environment.

But is all of this enough? Working together to find solutions in both healthcare facilities and in our communities will help us advocate for our health in the long-term. It will also help us learn more and support the need for investments and ongoing efforts in IPC to combat AMR. Together, we can share consistent and clear messages and explore opportunities to make a difference in the strategies that address this issue. Let’s learn together and share what works in different settings for the benefit of everyone.

 

Claire Kilpatrick

Claire Kilpatrick is a graduate of the University of Glasgow in Infection Prevention and Control (IPC) and medical sciences. She was awarded a Doctor of Science by Glasgow Caledonian University in 2023 and is a member of the faculty of travel medicine at the Royal College of Physicians and Surgeons (Glasgow). You can read more about her experience here as an independent advisor to The AMR Narrative.

Dr Marie-Anne Bouldouyre

Dr Marie-Anne Bouldouyre is an infectious diseases physician and hospital practitioner in Paris. Twelve years of clinical work in a suburban hospital shaped her understanding of access to care, patient relationships, and the daily reality of antimicrobial resistance.

Since 2022, she has led the Regional Antibiotic Stewardship Centre in Île-de-France and coordinates the national network, working with a multidisciplinary team to promote responsible antibiotic use and strengthen collaboration among healthcare professionals. She also continues to manage complex infections at Saint-Louis Hospital.

Convinced that antimicrobial resistance cannot be tackled by healthcare workers alone, she advocates for the active involvement of patients : understanding, questioning, and taking part in decisions about antibiotics. Their stories are essential to making this issue visible and concrete.

She is proud to collaborate with initiatives such as The AMR Narrative and hopes to foster similar projects in France to give patients a voice in this shared fight.

Dr Erva Cinar

Dr Erva Cinar is a London based paediatric resident doctor and clinical researcher with interest in infectious diseases.

She is currently completing a Master’s in Public Health at the London School of Hygiene & Tropical Medicine. Through the World Medical Association’s Junior Doctor’s Network (WMA-JDN) AMR Working Group, she engages in policy and advocacy on antimicrobial resistance and stewardship at global level.

Alongside her clinical and academic roles, she works with the Royal College of Paediatrics and Child Health (RCPCH) and the International Child Health Group (ICHG); leads on organising teaching resources and educational events to improve research skills for UK paediatric trainees and for global child health professionals.

Hamu Madzedze

Hamu Madzedze is a seasoned Zimbabwean journalist with over 15 years’ experience.

She previously worked for the Zimbabwe Broadcasting Corporation as a reporter and sub-editor, before establishing an independent website, 365HealthDiaries, which focuses on health and gender issues.

She holds a BA in Media Studies and a BA (Special Honours) in Communication and Media from the Zimbabwe Open University, as well as a diploma from the Christian College of Southern Africa.

Her work has been recognised with several awards, including the Global AMR Special Mention Award (2024), the Sexual Health Rights and Equity Fellowship Special Mention Award (2025), and the Merck Foundation Award (2024) for outstanding coverage of health issues, gender, infertility, and genital mutilation, where she achieved third position in the Online Category.

Hamu is passionate about addressing AMR through the media.

Jomana F. Musmar

Dr. Jomana Musmar is a distinguished global policy expert and proactive leader with over fifteen years of government experience in strategic planning, operational design, and policy execution. Renowned for simplifying complex topics with expertise and diplomacy, she has spearheaded innovative solutions to global health challenges, shaped impactful policies, and advanced national and international missions.

As the Executive Director of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, she established and led the council’s operations, liaising with over 600 experts, worldwide, across government, industry, and academia. Her efforts culminated in the development of critical recommendations addressing antimicrobial resistance and interrelated One Health issues, influencing both domestic and global health strategies.

In her tenure as Deputy Director of Strategic Initiatives for the Office of Infectious Diseases and HIV/AIDS Policy, at the US Department of Health and Human Services, Dr. Musmar oversaw the formulation and implementation of national health strategies for vaccines and a range of infectious diseases including HIV/AIDS and viral hepatitis. Her leadership and technical expertise facilitated groundbreaking policies during national emergencies, including responses to the COVID-19 pandemic, and initiatives to combat congenital syphilis and childhood vaccination disruptions. Dr. Musmar holds a Ph.D. in Biodefense from George Mason University, a Master’s degree in Biomedical Science policy and Advocacy from Georgetown University, and is a Lean Six Sigma Black Belt. Fluent in English and Arabic, she is a sought-after speaker and advisor, having represented the United States at premier global health conferences.

Her published works on antimicrobial resistance, pandemic preparedness, and national health security underscore her reputation as a thought leader and innovator in public health and biodefense.

Chris Shaffer

Chris Shaffer was a music, special education teacher, and high school principal for 45 years. At the end of his educational career, he was thrust into the world of AMR infections when a number of abdominal surgeries left him with an E-coli infection which failed to respond to antibiotics. After doctors in the USA left him with little hope for a cure, diminishing health, and a bleak prognosis, he set out on his own.

Chris found success in phage therapy at the Eliava Phage Therapy Center in Tbilisi, Georgia. With phage therapy giving Chris his life back, he has dedicated his retirement years to advocating for and helping raise awareness of phage therapy used for AMR infections. He tells the story of his phage journey in a book titled, Finding Phage: How I Partnered with a Friendly Virus to Cure My Deadly Bacterial Superinfection. His website, phagetherpyusa.com helps others learn to understand the healing power of phage therapy.

Demi Christofi

Demi is an Associate Scientific Director at a medical communications agency, with a background in microbiology and a longstanding focus on antimicrobial resistance. She holds an MSc in Microbiology, where she first became interested in the global challenge of resistance and the need to bring scientific understanding to wider audiences.

Demi’s career has centred on a simple but powerful belief: that how we communicate science matters. Her work focuses on making complex data clear, engaging, and accessible – whether for healthcare professionals, policy makers, or the patients most affected by infection and resistance. She has contributed to a wide range of AMR-focused projects, including educational programmes, congress communications and stewardship initiatives.

A central thread in Demi’s work is the importance of the patient voice. She is passionate about making sure real-world experiences of treatment failure, recurrent infections, and the anxiety surrounding resistance are not lost in the data. She believes that listening to patients and involving them meaningfully is essential for shaping more effective, human-centred responses to AMR.

Demi is also a strong advocate of the One Health approach, recognising AMR as a complex, interconnected issue that spans human health, animal health, and the environment. She is particularly drawn to efforts that move beyond siloed thinking and focus on practical, joined-up solutions.

In 2025, Demi joined The AMR Narrative as an Independent Advisor, where she supports the charity’s mission to centre communication, community, and inclusion in the global AMR response.

Outside of work, she is a Girlguiding unit leader and a qualified yoga teacher. These roles reflect her commitment to care, learning, and creating supportive spaces for others.

Andrea Hartley

Andrea has worked in health communications and campaigning for 3 decades. She is committed to fighting AMR through timely and appropriate communications globally,.

Andrea set up Skating Panda, the creative social and environmental impact consultancy, over a decade ago and drives its impact and growth. Focused on original and lasting public interest communications as well as issue strategy and advocacy, the Panda team has a track record of prompting tipping points in the status quo that drive better social and planetary outcomes.

Andrea’s combination of commercial marketing and development experience with deep issue knowledge have been sought by decision-makers at global summits, corporate and NGO board members, and have enabled her to set up multi-million fundraising platforms and push through policies that change and save lives. 

Andrea is Vice Chair of mothers2mothers, the world’s largest employer of women living with HIV, and a Board Director of Maymessy, a food poverty social enterprise.

A lifelong advocate for gender equality, she played a key role in establishing the UK’s Women’s Equality Party.

Esmita Charani

Professor Esmita Charani is a pharmacist and researcher investigating how we use antibiotics in different cultural and social contexts. She works with teams in the UK, India, and South Africa to develop research programmes investigating all aspects of antimicrobial resistance in human populations with a focus in hospital settings.

She has experience in communicating her research with patients and the public through various media including animations, blogs, and educational videos.